Inventor · disambiguated record
Daniela Carmen Oniciu
Also filed as: ONICIU DANIELA CARMEN
28 granted patents·21 pending applications·171 citations·filing 2003–2025
96Inventor score
Files withESPERVITA THERAPEUTICS INC11CERENIS THERAPEUTICS HOLDING SA8GEMPHIRE THERAPEUTICS INC6ABIONYX PHARMA SA4OCUPHIRE PHARMA INC4
Top patents by PatentIndex Score
49 records- 0198US11566005B2Highly pure phentolamine mesylate and methods for making sameOCUPHIRE PHARMA INC·Filed 2022·Granted Jan 31, 2023·8 cites·21 claims
- 0297US11267778B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2021·Granted Mar 8, 2022·6 cites·2 claims
- 0397US11098002B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2020·Granted Aug 24, 2021·5 cites·1 claims
- 0497US11084773B1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2021·Granted Aug 10, 2021·5 cites·1 claims
- 0596US12252467B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2024·Granted Mar 18, 2025·1 cites·16 claims
- 0696US11976044B2Highly pure phentolamine mesylateOCUPHIRE PHARMA INC·Filed 2022·Granted May 7, 2024·4 cites·25 claims
- 0796US8067466B2Cycloalkyl-hydroxyl compounds and compositions for cholesterol managementDASSEUX JEAN-LOUIS HENRI·Filed 2008·Granted Nov 29, 2011·20 cites·21 claims
- 0895US12180151B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2023·Granted Dec 31, 2024·1 cites·4 claims
- 0995US11730712B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Granted Aug 22, 2023·3 cites·21 claims
- 1094US11998587B2Lipoprotein complexes and manufacturing and uses thereofABIONYX PHARMA SA·Filed 2023·Granted Jun 4, 2024·1 cites·19 claims
- 1194US11969456B2Lipoprotein complexes and manufacturing and uses thereofABIONYX PHARMA SA·Filed 2023·Granted Apr 30, 2024·1 cites·17 claims
- 1294US11376309B2Lipoprotein complexes and manufacturing and uses thereofCERENIS THERAPEUTICS HOLDING S A·Filed 2019·Granted Jul 5, 2022·7 cites·18 claims
- 1394US8084498B2Ketone compounds and compositions for cholesterol management and related usesDASSEUX JEAN-LOUIS HENRI·Filed 2009·Granted Dec 27, 2011·20 cites·14 claims
- 1493US9849104B2Treatment of NASH with gemcabeneGEMPHIRE THERAPUETICS INC·Filed 2017·Granted Dec 26, 2017·21 cites·15 claims
- 1592US10322163B2Lipoprotein complexes and manufacturing and uses thereofCERENIS THERAPEUTICS HOLDING S A·Filed 2015·Granted Jun 18, 2019·8 cites·29 claims
- 1692US7304093B2Ketone compounds and compositions for cholesterol management and related usesESPERION THERAPEUTICS INC·Filed 2003·Granted Dec 4, 2007·34 cites·25 claims
- 1789US11737995B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Granted Aug 29, 2023·4 cites·20 claims
- 1889US10328119B2Lipoprotein complexes and manufacturing and uses thereofCERENIS THERAPEUTICS HOLDING S A·Filed 2014·Granted Jun 25, 2019·8 cites·25 claims
- 1986US2025302916A1Lipoprotein complexes and manufacturing and uses thereofABIONYX PHARMA SA·Filed 2025·Application pending·0 cites
- 2082US12364735B2Lipoprotein complexes and manufacturing and uses thereofABIONYX PHARMA SA·Filed 2022·Granted Jul 22, 2025·0 cites·22 claims
- 2182US2023007838A1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2281US8349833B2Compounds, compositions and methods useful for cholesterol mobilisationCERENIS THERAPEUTICS HOLDING SA·Filed 2011·Granted Jan 8, 2013·7 cites·8 claims
- 2380US2025367149A1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2479US9085585B2Compounds, compositions and methods useful for cholesterol mobilizationCERENIS THERAPEUTICS HOLDING SA·Filed 2012·Granted Jul 21, 2015·3 cites·11 claims
- 2578US2024308967A1Highly pure phentolamine mesylate and methods for making sameOCUPHIRE PHARMA INC·Filed 2024·Application pending·0 cites
- 2677US2022402851A1Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2774US12396972B2Functionalized long-chain hydrocarbon mono- and di-carboxylic acids and derivatives thereof, and their use for the prevention or treatment of diseaseESPERVITA THERAPEUTICS INC·Filed 2023·Granted Aug 26, 2025·0 cites·3 claims
- 2873US12503422B2Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforNEUROBO PHARMACEUTICALS INC·Filed 2022·Granted Dec 23, 2025·0 cites·8 claims
- 2973US12312308B2Salts and esters of APX3330 and therapeutic uses thereofOPUS GENETICS INC·Filed 2024·Granted May 27, 2025·0 cites·27 claims
- 3071US9708354B2Methods for the synthesis of sphingomyelins and dihydrosphingomyelinsCERENIS THERAPEUTICS HOLDING SA·Filed 2013·Granted Jul 18, 2017·2 cites·5 claims
- 3169US9713619B2Compounds, compositions and methods useful for cholesterol mobilizationCERENIS THERAPEUTICS HOLDING SA·Filed 2015·Granted Jul 25, 2017·1 cites·9 claims
- 3269US9643915B2Methods for the synthesis of sphingomyelins and dihydrosphingomyelinsCERENIS THERAPEUTICS HOLDING SA·Filed 2015·Granted May 9, 2017·1 cites·4 claims
- 3366US2024101505A1Salts and esters of apx3330 and therapeutic uses thereofOCUPHIRE PHARMA INC·Filed 2023·Application pending·0 cites
- 3462US10449154B2Treatment of NASH with GemcabeneGEMPHIRE THERAPEUTICS INC·Filed 2017·Granted Oct 22, 2019·0 cites·20 claims
- 3561US2012232005A1Lipoprotein complexes and manufacturing and uses thereofDASSEUX JEAN-LOUIS·Filed 2012·Application pending·0 cites
- 3660US2020061072A1Compounds, compositions and methods useful for cholesterol mobilizationCERENIS THERAPEUTICS HOLDING SA·Filed 2019·Application pending·0 cites
- 3758US2018325825A1Gemcabene combinations for the treatment of cardiovascular diseaseGEMPHIRE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3855US2025162995A1Phentolamine mesylate and therapeutic uses thereofOPUS GENETICS INC·Filed 2024·Application pending·0 cites
- 3955US2017172955A1Treatment of Mixed DyslipidemiaGEMPHIRE THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4055US2005020694A1Sulfide and disulfide compounds and compositions for cholesterol management and related usesFiled 2003·Application pending·0 cites
- 4154US2014316154A1Methods for the synthesis of sphingomyelins and dihydrosphingomyelinsCERENIS THERAPEUTICS HOLDING SA·Filed 2014·Application pending·0 cites
- 4254US2017204122A1Methods for the synthesis of sphingomyelins and dihydrosphingomyelinsCERENIS THERAPEUTICS HOLDING SA·Filed 2017·Application pending·0 cites
- 4350US2010015220A1Niacin and nsaid combination therapyWETTERAU JOHN R·Filed 2009·Application pending·0 cites
- 4450US2020148617A1Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforGEMPHIRE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4548US2018297929A1Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforGEMPHIRE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4648US2020253877A1Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use thereforNEUROBO PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 4744US2004204502A1Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related usesFiled 2003·Application pending·0 cites
- 4838US2019008779A1Gemcabene compositions and methods of use thereofGEMPHIRE THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4935US2011092517A1Use of PPAR Delta Ligands for the Treatment or Prevention of Inflammation or Energy Metabolism/Production Related DiseasesCERENIS THERAPEUTICS S A & NIPPON CHEMIPHAR CO LTD·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniela Carmen Oniciu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →